(Q39658722)

13 September 2017

title

Personalized therapy in breast cancer (English)

1 reference

13 September 2017

2

Andreas Schneeweiss

1 reference

13 September 2017

1

Frederik Marmé

1 reference

13 September 2017

publication date

20 January 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

35 Suppl 1

1 reference

13 September 2017

page(s)

28-33

1 reference

Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer

13 September 2017

cites work

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

Deconstructing the molecular portraits of breast cancer

21 January 2018

1 reference

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy

21 January 2018

1 reference

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays

21 January 2018

1 reference

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study

21 January 2018

1 reference

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

21 January 2018

1 reference

Additional value and potential use of the 70-gene prognosis signature in node-negative breast cancer in daily clinical practice.

21 January 2018

1 reference

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

21 January 2018

1 reference

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer.

21 January 2018

1 reference

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.

21 January 2018

1 reference

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 January 2018

1 reference

International network of cancer genome projects

21 January 2018

1 reference

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000334973

1 reference

13 September 2017

1 reference